Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Dianne Johnston"'
Autor:
Daniel Campos, Pedro Santabárbara, José Rodrigues Pereira, Maximiliano Van Kooten, Andrea Bezjak, Savitree Maoleekoonpiroj, Mircea Dediu, Vera Hirsh, Michael Smylie, Sumitra Thongprasert, Renato G. Martins, Eng Huat Tan, Gary M. Clark, B. Findlay, Frances A. Shepherd, Lesley Seymour, Dongsheng Tu, Tudor Ciuleanu, Dianne Johnston
Publikováno v:
New England Journal of Medicine. 353:123-132
We conducted a randomized, placebo-controlled, double-blind trial to determine whether the epidermal growth factor receptor inhibitor erlotinib prolongs survival in non-small-cell lung cancer after the failure of first-line or second-line chemotherap
Autor:
Himu Lukka, Luis Souhami, P Drouin, Gd Maclean, Michael Brundage, J.F. Jeffrey, Robert Pearcey, Dianne Johnston, Dongsheng Tu, Gavin Stuart
Publikováno v:
Journal of Clinical Oncology. 20:966-972
PURPOSE: To test the hypothesis that cisplatin (CDDP) administered concurrently with standard radiotherapy (RT) would improve pelvic control and survival in patients with advanced squamous cell cancer of the cervix. PATIENTS AND METHODS: A total of 2
Autor:
Dave Stewart, David Walde, James J. Rusthoven, Elissa McMurtrie, Louise Yelle, B. Findlay, Harbhajan Dhaliwal, F A Shepherd, David Warr, Paul Hoskins, Dianne Johnston, Francis Laberge, Jean Latreille, David Mee
Publikováno v:
Supportive Care in Cancer. 3:307-312
The object of the study was to determine whether dexamethasone improved the efficacy of the serotonin receptor (5-HT3) antagonist granisetron in controlling acute (within 24 h) emesis in cancer patients receiving high-dose cisplatin chemotherapy and
Autor:
Louise Yelle, D. Stewart, David Mee, Paul Hoskins, Jean Latreille, Scott Ernst, James J. Rusthoven, Dianne Johnston, Francis Laberge, Benny Zee, F A Shepherd, Harbhajan Dhaliwal, David Warr, Christopher R. Williams, B. Findlay, Laurie Nishimura, Elissa McMurtrie, D Osoba, J. L. Pater, David Walde
Publikováno v:
Europe PubMed Central
PURPOSE To evaluate the roles of granisetron and dexamethasone for emesis control on days 2 through 7 after the administration of cisplatin in doses of 50 mg/m2 or greater to patients who had not previously received chemotherapy. PATIENTS AND METHODS
Autor:
Dianne Johnston, C.K.O. Williams, S. Ernst, Benny Zee, L. Nishimura, L. Yelle, E. McMurtrie, H. Dhahwal, B. Findlay, Francis Laberge, J. Rusthoven, Joseph L. Pater, P. Hoskins, D. Stewart, J. Latreille
Publikováno v:
European Journal of Cancer. 31:S251
The combination of dexamethasone (D) and granisetron (G), a selective 5HT 3 , receptor antagonist, has greatly reduced the incidence of emesis and nausea in the first 24 hours after HDCP (≥50 mg/m 2 ). How best to control emesis after this time rem
Autor:
Dianne Johnston
Publikováno v:
Academic Therapy Quarterly. 3:77-80
A discussion of the various definitions of the problem described as "learning disorders," and the confusion caused by inconsistencies in meaning.
Autor:
Maunsell E; Elizabeth Maunsell, Centre de recherche du Centre hospitalier universitaire (CHU) de Québec, (Axe Oncologie), Québec; Pierre Dubé, Hôpital Maisonneuve-Rosemont, Montreal, QC; Andrew L. Cooke, CancerCare Manitoba, Winnipeg, MB; Silvana Spadafora, Algoma District Cancer Program, Sault Ste. Marie, ON; Lavina Lickley, Women's College Hospital; Angela M. Cheung, University Health Network, University of Toronto, Toronto; Dianne Johnston, Andrea Hiltz, Michael Brundage, Dongsheng Tu, and Harriet Richardson, National Cancer Institute of Canada Clinical Trials Group; Joseph Pater, Queens University, Kingston, ON; Susan L. Ellard, British Columbia Cancer Agency-Southern Interior, Kelowna; Karen A. Gelmon, British Columbia Cancer Agency, Vancouver, BC, Canada; Paul E. Goss, Massachusetts General Hospital, Boston, MA; Rowan T. Chlebowski, University of California at Los Angeles Medical Centre, Torrance, CA; James N. Ingle and Sandhya Pruthi, Mayo Clinic, Rochester, MN; José E. Alés Martínez, Hospital N. S. Sonsoles, Ávila; Amparao Ruiz, Instituto Valenciano de Oncologia, Valencia, Spain; Gloria E. Sarto, Center for Women's Health & Health Research, University of Wisconsin, Madison, WI; Carol J. Fabian, University of Kansas Medical Center, Kansas City, KS; Pascal Pujol, CHU-Hôpital Arnaud de Villeneuve, Montpellier, France; Susan Hendrix, Hutzel Women's Health Specialists, Detroit, MI; Debra W. Thayer, MedStar Health Research Institute, Hyattsville, MD; Kendrith M. Rowland, Carle Cancer Centre/Mills Breast Cancer Institute, Urbana, IL; and Jean Wactawski-Wende, State University of New York at Buffalo, Buffalo, NY., Goss PE, Chlebowski RT, Ingle JN, Alés-Martínez JE, Sarto GE, Fabian CJ, Pujol P, Ruiz A, Cooke AL, Hendrix S, Thayer DW, Rowland KM, Dubé P, Spadafora S, Pruthi S, Lickley L, Ellard SL, Cheung AM, Wactawski-Wende J, Gelmon KA, Johnston D, Hiltz A, Brundage M, Pater JL, Tu D, Richardson H
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2014 May 10; Vol. 32 (14), pp. 1427-36. Date of Electronic Publication: 2014 Apr 07.